Cargando…

Towards Evidence-Based Implementation of Pharmacogenomics in Southern Africa: Comorbidities and Polypharmacy Profiles across Diseases

Pharmacogenomics may improve patient care by guiding drug selection and dosing; however, this requires prior knowledge of the pharmacogenomics of drugs commonly used in a specific setting. The aim of this study was to identify a preliminary set of pharmacogenetic variants important in Southern Afric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Soko, Nyarai Desiree, Muyambo, Sarudzai, Dandara, Michelle T. L., Kampira, Elizabeth, Blom, Dirk, Jones, Erika S. W., Rayner, Brian, Shamley, Delva, Sinxadi, Phumla, Dandara, Collet
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10455498/ https://www.ncbi.nlm.nih.gov/pubmed/37623436 http://dx.doi.org/10.3390/jpm13081185

Ejemplares similares

Warfarin Pharmacogenomics for Precision Medicine in Real-Life Clinical Practice in Southern Africa: Harnessing 73 Variants in 29 Pharmacogenes
por: Muyambo, Sarudzai, et al.
Publicado: (2022)

The COVID-19 Pandemic and Explaining Outcomes in Africa: Could Genomic Variation Add to the Debate?
por: Soko, Nyarai D., et al.
Publicado: (2022)

A cost effective RFLP method to genotype Solute carrier organic anion 1B1 (SLCO1B1) c.1929A>C (p.Leu643Phe, rs34671512); a variant with potential effect on rosuvastatin pharmacokinetics
por: Soko, Nyarai D., et al.
Publicado: (2018)

Profiling of warfarin pharmacokinetics‐associated genetic variants: Black Africans portray unique genetic markers important for an African specific warfarin pharmacogenetics‐dosing algorithm
por: Ndadza, Arinao, et al.
Publicado: (2021)

African Pharmacogenomics Consortium: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa: Consolidating pharmacogenomics knowledge, capacity development and translation in Africa
por: Dandara, Collet, et al.
Publicado: (2019)

Is there a role of pharmacogenomics in Africa
por: Matimba, A., et al.
Publicado: (2016)

Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation
por: Warnich, Louise, et al.
Publicado: (2011)

Mitochondrial DNA Subhaplogroups L0a2 and L2a Modify Susceptibility to Peripheral Neuropathy in Malawian Adults on Stavudine Containing Highly Active Antiretroviral Therapy
por: Kampira, Elizabeth, et al.
Publicado: (2013)

Genetic variation in the 3′-UTR of CYP1A2, CYP2B6, CYP2D6, CYP3A4, NR1I2, and UGT2B7: potential effects on regulation by microRNA and pharmacogenomics relevance
por: Swart, Marelize, et al.
Publicado: (2014)

A cervical cancer biorepository for pharmacogenomics research in Zimbabwe
por: Kuguyo, Oppah, et al.
Publicado: (2022)

Pharmacogenomics Implications of Using Herbal Medicinal Plants on African Populations in Health Transition
por: Thomford, Nicholas E., et al.
Publicado: (2015)

Beta-globin gene haplotypes and selected Malaria-associated variants among black Southern African populations
por: Pule, G. D., et al.
Publicado: (2017)

Disease burden and the role of pharmacogenomics in African populations
por: Mpye, K. L., et al.
Publicado: (2017)

Immunogenetics and pharmacogenetics of allergic asthma in Africa
por: Mabelane, Tshegofatso, et al.
Publicado: (2023)

MicroRNA Mediated Changes in Drug Metabolism and Target Gene Expression by Efavirenz and Rifampicin In Vitro: Clinical Implications
por: Swart, Marelize, et al.
Publicado: (2019)

The Extracellular Matrix: Its Composition, Function, Remodeling, and Role in Tumorigenesis
por: Dzobo, Kevin, et al.
Publicado: (2023)

9β Polymorphism of the Glucocorticoid Receptor Gene Appears to Have Limited Impact in Patients with Addison’s Disease
por: Ross, Ian Louis, et al.
Publicado: (2014)

Oncology Clinical Trials in Africa: Partnering for Quality
por: Shamley, Delva, et al.
Publicado: (2021)

Availability, effectiveness and safety of ART in sub-Saharan Africa: a systematic review
por: Botha, Barend, et al.
Publicado: (2018)

Promoting Undetectable Equals Untransmittable in Sub-Saharan Africa: Implication for Clinical Practice and ART Adherence
por: Thomford, Nicholas Ekow, et al.
Publicado: (2020)

The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa
por: Chattopadhyay, Koushik, et al.
Publicado: (2015)

The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer
por: Li, Dongping, et al.
Publicado: (2010)

Editorial: Metabolism of anti-cancer drugs: Interplay involving pharmacology and pharmacokinetics
por: Bapiro, Tashinga E., et al.
Publicado: (2022)

The Tumor Microenvironment in Tumorigenesis and Therapy Resistance Revisited
por: Dzobo, Kevin, et al.
Publicado: (2023)

Pharmacogenomic Approaches for Automated Medication Risk Assessment in People with Polypharmacy
por: Liu, Jiazhen, et al.
Publicado: (2018)

Conversion Disorder in a Pharmacogenomics, Polypharmacy Patient: Case Report
por: Schuh, Michael J., et al.
Publicado: (2021)

An early warning surveillance programme for detecting upper limb deterioration after treatment for breast cancer: A novel technology supported system
por: Shamley, Delva, et al.
Publicado: (2015)

Suprasellar Cysticercosis Cyst with Optic Nerve Compression Masquerading as an Arachnoid Cyst
por: Musara, Aaron, et al.
Publicado: (2019)

Effect of obesity on dolutegravir exposure in Black Southern African adults living with HIV
por: Mondleki, Enkosi, et al.
Publicado: (2022)

Weight gain on dolutegravir: Association is not the same as causation
por: Maartens, Gary, et al.
Publicado: (2023)

ABCB1 4036A>G and 1236C>T Polymorphisms Affect Plasma Efavirenz Levels in South African HIV/AIDS Patients
por: Swart, Marelize, et al.
Publicado: (2012)

Screening of variants for lactase persistence/non-persistence in populations from South Africa and Ghana
por: Torniainen, Suvi, et al.
Publicado: (2009)

Precision Medicine: Applied Concepts of Pharmacogenomics in Patients with Various Diseases and Polypharmacy
por: Michaud, Veronique, et al.
Publicado: (2021)

CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women
por: Chatterjee, Koushik, et al.
Publicado: (2010)

Pharmacogenetics of tenofovir renal toxicity in HIV-positive Southern Africans
por: Mateza, Somila, et al.
Publicado: (2023)

The potential role of angiogenesis in the development of shoulder pain, shoulder dysfunction, and lymphedema after breast cancer treatment
por: Mafu, Trevor S, et al.
Publicado: (2018)

KDR inferred haplotype is associated with upper limb dysfunction in breast cancer survivors of mixed ancestry
por: Mafu, Trevor S, et al.
Publicado: (2019)

Regulatory VCAN polymorphism is associated with shoulder pain and disability in breast cancer survivors
por: Mafu, Trevor S., et al.
Publicado: (2021)

Polymorphisms in COMT and OPRM1 Collectively Contribute to Chronic Shoulder Pain and Disability in South African Breast Cancer Survivors’
por: Firfirey, Firzana, et al.
Publicado: (2022)

An Application of the Multivariate Linear Mixed Model to the Analysis of Shoulder Complexity in Breast Cancer Patients
por: Oskrochi, Gholamreza, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dpdf6ta0o7ep9tusbjsuj4f2ju